Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.
Maria Lia ScribanoAnnalisa AratariBenedetto NeriCristina BezzioPaola BalestrieriValentina BaccoliniGiuliano FalascoCaterina CamastraPaolo PantanellaRita MonterubbianesiAlessandro TullioSimone SaibeniClaudio PapiLivia BianconeRocco CosintinoRoberto FaggianiPublished in: Therapeutic advances in gastroenterology (2022)
Our study findings confirm the effectiveness and safety of ustekinumab in patients with CD after failure of or intolerance to anti-TNF-α therapy.